Bourne Lent Asset Management’s Merck MRK Stock Holding History

Bourne Lent Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$560K	Hold	4,357	–	–	0.19%	43
2026 Q1	$524K	Sell	4,357 -300	-6%	-$34.6K	0.19%	42
2025 Q4	$490K	Hold	4,657	–	–	0.16%	42
2025 Q3	$391K	Sell	4,657 -80	-2%	-$6.59K	0.14%	45
2025 Q2	$375K	Hold	4,737	–	–	0.15%	47
2025 Q1	$425K	Hold	4,737	–	–	0.18%	40
2024 Q4	$471K	Sell	4,737 -730	-13%	-$75.3K	0.18%	40
2024 Q3	$621K	Hold	5,467	–	–	0.24%	34
2024 Q2	$677K	Hold	5,467	–	–	0.26%	35
2024 Q1	$721K	Hold	5,467	–	–	0.29%	34
2023 Q4	$596K	Sell	5,467 -200	-4%	-$20.8K	0.24%	37
2023 Q3	$583K	Sell	5,667 -300	-5%	-$32.3K	0.26%	38
2023 Q2	$689K	Hold	5,967	–	–	0.24%	36
2023 Q1	$635K	Hold	5,967	–	–	0.24%	38
2022 Q4	$662K	Hold	5,967	–	–	0.28%	36
2022 Q3	$514K	Hold	5,967	–	–	0.22%	37
2022 Q2	$544K	Hold	5,967	–	–	0.22%	36
2022 Q1	$490K	Hold	5,967	–	–	0.15%	44
2021 Q4	$457K	Hold	5,967	–	–	0.12%	46
2021 Q3	$448K	Hold	5,967	–	–	0.13%	44
2021 Q2	$464K	Sell	5,967 -286	-5%	-$21.3K	0.13%	43
2021 Q1	$460K	Hold	6,253	–	–	0.15%	44
2020 Q4	$488K	Sell	6,253 -734	-11%	-$56.1K	0.16%	42
2020 Q3	$553K	Hold	6,987	–	–	0.21%	36
2020 Q2	$516K	Hold	6,987	–	–	0.22%	36
2020 Q1	$513K	Hold	6,987	–	–	0.28%	35
2019 Q4	$606K	Hold	6,987	–	–	0.29%	34
2019 Q3	$561K	Hold	6,987	–	–	0.27%	32
2019 Q2	$559K	Hold	6,987	–	–	0.27%	32
2019 Q1	$554K	Hold	6,987	–	–	0.27%	33
2018 Q4	$509K	Hold	6,987	–	–	0.3%	32
2018 Q3	$473K	Hold	6,987	–	–	0.23%	42
2018 Q2	$405K	Buy	6,987 +84	+1%	+$4.74K	0.21%	43
2018 Q1	$359K	Sell	6,903 -315	-4%	-$17K	0.2%	48
2017 Q4	$388K	Hold	7,218	–	–	0.21%	46
2017 Q3	$441K	Hold	7,218	–	–	0.23%	42
2017 Q2	$441K	Sell	7,218 -419	-5%	-$25.5K	0.24%	38
2017 Q1	$463K	Hold	7,637	–	–	0.25%	40
2016 Q4	$429K	Buy	7,637 +839	+12%	+$49.1K	0.26%	41
2016 Q3	$405K	Hold	6,798	–	–	0.3%	36
2016 Q2	$374K	Hold	6,798	–	–	0.29%	38
2016 Q1	$343K	Hold	6,798	–	–	0.27%	38
2015 Q4	$343K	Hold	6,798	–	–	0.26%	39
2015 Q3	$320K	Hold	6,798	–	–	0.26%	39
2015 Q2	$369K	Hold	6,798	–	–	0.29%	40
2015 Q1	$373K	Buy	+6,798	New	+$385K	0.28%	41

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Bourne Lent Asset Management's MRK Position: Q2 2026 in Review

Bourne Lent Asset Management held its Merck (MRK) position steady in Q2 2026 at 4,357 shares worth $560K. The position accounts for 0.19% of the portfolio, ranked #43.

Bourne Lent Asset Management first reported a position in MRK in Q1 2015 and has held it in 46 quarters since. The position peaked at $721K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Bourne Lent Asset Management held 4,357 shares of Merck worth $560K as of Q2 2026.
Bourne Lent Asset Management left its Merck share count unchanged in Q2 2026.
Merck made up 0.19% of Bourne Lent Asset Management's portfolio in Q2 2026, its #43 holding.
Bourne Lent Asset Management first reported a position in Merck in Q1 2015 and has held it in 46 quarters since.
Bourne Lent Asset Management's Merck position peaked at $721K in Q1 2024.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bourne Lent Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.